Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Protein Tyrosine Phosphatases in Cancer (eBook)

eBook Download: PDF
2016 | 1st ed. 2016
VIII, 360 Seiten
Springer New York (Verlag)
978-1-4939-3649-6 (ISBN)

Lese- und Medienproben

Protein Tyrosine Phosphatases in Cancer -
Systemvoraussetzungen
149,79 inkl. MwSt
(CHF 146,30)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book aims to bridge the gap in understanding how protein-tyrosine phosphatases (PTPs), which carry out the reverse reaction of tyrosine phosphorylation, feature in cancer cell biology. The expertly authored chapters will first review the general features of the PTP superfamily, including their overall structure and enzymological properties; use selected examples of individual PTP superfamily members, to illustrate emerging data on the role of PTPs in cancer; and will review the current status of PTP-based drug development efforts.

Protein Tyrosine Phosphatases in Cancer,from renowned researchers Benjamin Neel and Nicholas Tonks, is invaluable reading for researchers in oncology, stem cell signaling,and biochemistry. 


Dr. Neel earned his PhD in Viral Oncology from The Rockefeller University and his MD degree from Cornell University Medical School. After completing residency and post-doctoral training at Harvard institutions, he was appointed Assistant Professor of Medicine at Harvard Medical School (HMS), and began his own independent research laboratory in the Molecular Medicine Unit at Beth Israel Hospital in Boston, now known as Beth Israel Deaconess Medical Center (BIDMC). He also served as the Director of the Cancer Biology Program and as Deputy Director for Basic Research, Hematology Division at BIDMC. Currently, Dr. Neel is Director of the Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center, as well as a Professor in the Department of Medicine at NYU.

Dr Neel is the author of over 160 original papers and 25 invited reviews. He was the inaugural recipient of the Gertrude Elion Award of the American Association for Cancer Research and holds an NIH MERIT award. His current scientific interests focus on cell signaling, with a particular emphasis on protein-tyrosine phosphatases (PTPs), as well as tumor stem cell signaling and the roles of Shp2 and its binding proteins in several human diseases. 

Dr Tonks was educated at Oxford University and the University of Dundee, where he earned his PhD. He subsequently conducted postdoctoral studies at the University of Washington with Edmond H.  Fischer, and moved to the Cold Spring Harbor Laboratory, where he was promoted to his current position of full Professor. 

Dr. Tonks has published over 180 papers in the field and has been granted 10 patents.  His research has been recognized by several awards, including a MERIT Award from the NIH and the Colworth Medal (British Biochemical Society).  He is a Fellow of the Royal Society and was a Pew Scholar in the Biomedical Sciences. Dr. Tonks' research focuses on functional analysis of members of the PTP family, using various approaches including RNA interference, in cell and animal models of disease.




This book aims to bridge the gap in understanding how protein-tyrosine phosphatases (PTPs), which carry out the reverse reaction of tyrosine phosphorylation, feature in cancer cell biology. The expertly authored chapters will first review the general features of the PTP superfamily, including their overall structure and enzymological properties; use selected examples of individual PTP superfamily members, to illustrate emerging data on the role of PTPs in cancer; and will review the current status of PTP-based drug development efforts.Protein Tyrosine Phosphatases in Cancer,from renowned researchers Benjamin Neel and Nicholas Tonks, is invaluable reading for researchers in oncology, stem cell signaling,and biochemistry. 

Dr. Neel earned his PhD in Viral Oncology from The Rockefeller University and his MD degree from Cornell University Medical School. After completing residency and post-doctoral training at Harvard institutions, he was appointed Assistant Professor of Medicine at Harvard Medical School (HMS), and began his own independent research laboratory in the Molecular Medicine Unit at Beth Israel Hospital in Boston, now known as Beth Israel Deaconess Medical Center (BIDMC). He also served as the Director of the Cancer Biology Program and as Deputy Director for Basic Research, Hematology Division at BIDMC. Currently, Dr. Neel is Director of the Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center, as well as a Professor in the Department of Medicine at NYU.Dr Neel is the author of over 160 original papers and 25 invited reviews. He was the inaugural recipient of the Gertrude Elion Award of the American Association for Cancer Research and holds an NIH MERIT award. His current scientific interests focus on cell signaling, with a particular emphasis on protein-tyrosine phosphatases (PTPs), as well as tumor stem cell signaling and the roles of Shp2 and its binding proteins in several human diseases. Dr Tonks was educated at Oxford University and the University of Dundee, where he earned his PhD. He subsequently conducted postdoctoral studies at the University of Washington with Edmond H.  Fischer, and moved to the Cold Spring Harbor Laboratory, where he was promoted to his current position of full Professor. Dr. Tonks has published over 180 papers in the field and has been granted 10 patents.  His research has been recognized by several awards, including a MERIT Award from the NIH and the Colworth Medal (British Biochemical Society).  He is a Fellow of the Royal Society and was a Pew Scholar in the Biomedical Sciences. Dr. Tonks' research focuses on functional analysis of members of the PTP family, using various approaches including RNA interference, in cell and animal models of disease.

.-1 Introduction to the PTP Superfamily.-2 Receptor PTPs in Cancer.-3 Non-Receptor PTPs in Cancer.-4 HP2.-5 C-PTP.-6 PTP1B.-7 PTP-PEST.-8 Dual Specificity Phosphatases in Cancer.-9 Phosphatase-dependent roles for PTEN in Cancer.-10 Phosphatase-independent roles for PTEN in Cancer.-11 PRL family members in Cancer.-12 Cdc25 family.-13 PTPs, metabolism and cancer.-14 PTPs, metabolism and cancer.-15 Current status of PTP-based therapeutics.-16 Summary and Perspective 

Erscheint lt. Verlag 5.8.2016
Zusatzinfo VIII, 360 p. 28 illus., 19 illus. in color.
Verlagsort New York
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Pathologie
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Biologie Zellbiologie
Technik
Schlagworte CdC25 • Phosphatase • PTEN • SHP2 • TC-PTP
ISBN-10 1-4939-3649-2 / 1493936492
ISBN-13 978-1-4939-3649-6 / 9781493936496
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 8,6 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich